An Open Label, Randomized, Comparative Trial of the Safety and Efficacy of Wockhardt's Insulin analogue Glargine (GlaritusÂ) with Sanofi Aventis Insulin analogue Glargine (LantusÂ) given along with meal time bolus of rapid acting insulin (Lispro) in Type 1 diabetic patients. - SEGLAR

Trial Profile

An Open Label, Randomized, Comparative Trial of the Safety and Efficacy of Wockhardt's Insulin analogue Glargine (GlaritusÂ) with Sanofi Aventis Insulin analogue Glargine (LantusÂ) given along with meal time bolus of rapid acting insulin (Lispro) in Type 1 diabetic patients. - SEGLAR

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Insulin glargine; Insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SEGLAR
  • Sponsors Wockhardt
  • Most Recent Events

    • 21 Mar 2012 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
    • 21 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top